Literature DB >> 26477396

Validation of the total dysphagia risk score (TDRS) in head and neck cancer patients in a conventional and a partially accelerated radiotherapy scheme.

Daan Nevens1, Sarah Deschuymer1, Johannes A Langendijk2, Jean-François Daisne3, Fréderic Duprez4, Wilfried De Neve4, Sandra Nuyts5.   

Abstract

BACKGROUND AND
PURPOSE: A risk model, the total dysphagia risk score (TDRS), was developed to predict which patients are most at risk to develop grade ⩾2 dysphagia at 6 months following radiotherapy (RT) for head and neck cancer. The purpose of this study was to validate this model at 6 months and to investigate the power at earlier and later time-points. A second aim was to see if this model can be used in a partially accelerated RT regimen.
MATERIALS AND METHODS: 164 patients from 3 different centres treated with RT between 2008 and 2014 were included in the current study. Both physician-scored dysphagia and QoL data were prospectively obtained. The TDRS of all patients was correlated with the physician-scored dysphagia and the QoL data. To validate this prediction model, we tested the validity in terms of calibration and discrimination.
RESULTS: Partial acceleration had no influence on the TDRS. Regarding physician-scored dysphagia, there was a significant correlation with dysphagia grade ⩾2 at 1, 3, 6 and 9 months. The area-under-the-curve at 1 month was 0.85; at 3 months 0.80; at 6 months 0.85; at 9 months 0.86 and 0.79 at 12 months. Regarding QoL, TDRS correlates with PEG-tube usage at 6 and 12 months.
CONCLUSION: We found significant correlations between TDRS and dysphagia grade ⩾2 and PEG-tube usage.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dysphagia; Head and neck cancer; Quality of life; Radiotherapy; Total dysphagia risk score

Mesh:

Year:  2015        PMID: 26477396     DOI: 10.1016/j.radonc.2015.10.008

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Correlation of Patient- and Physician-Scored Dysphagia with Videofluoroscopies in Patients Treated with Radiotherapy for Head and Neck Cancer.

Authors:  D Nevens; A Goeleven; F Duprez; A Laenen; E Dejaeger; W De Neve; S Nuyts
Journal:  Dysphagia       Date:  2018-03-03       Impact factor: 3.438

2.  Does the total dysphagia risk score correlate with swallowing function examined by videofluoroscopy?

Authors:  Daan Nevens; Ann Goeleven; Fréderic Duprez; R Braeken; E Decabooter; M De Smet; L Lutters; Eddy Dejaeger; Wilfried De Neve; Sandra Nuyts
Journal:  Br J Radiol       Date:  2018-01-02       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.